194 related articles for article (PubMed ID: 28061021)
1. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
[TBL] [Abstract][Full Text] [Related]
2. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience.
Koelzer VH; Assarzadegan N; Dawson H; Mitrovic B; Grin A; Messenger DE; Kirsch R; Riddell RH; Lugli A; Zlobec I
J Pathol Clin Res; 2017 Jul; 3(3):171-178. PubMed ID: 28770101
[TBL] [Abstract][Full Text] [Related]
4. Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.
Zlobec I; Hädrich M; Dawson H; Koelzer VH; Borner M; Mallaev M; Schnüriger B; Inderbitzin D; Lugli A
Br J Cancer; 2014 Feb; 110(4):1008-13. PubMed ID: 24366305
[TBL] [Abstract][Full Text] [Related]
5. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of peritumoural and intratumoural budding in intestinal-type gastric adenocarcinoma.
Qi B; Liu L; Pan Y; Xu S; Li J
Arab J Gastroenterol; 2020 Jun; 21(2):111-116. PubMed ID: 32423856
[TBL] [Abstract][Full Text] [Related]
7. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
8. Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Shimazaki H; Hase K; Ueno H
Histopathology; 2019 Jun; 74(7):1005-1013. PubMed ID: 30698857
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
[TBL] [Abstract][Full Text] [Related]
10. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.
Fisher NC; Loughrey MB; Coleman HG; Gelbard MD; Bankhead P; Dunne PD
Histopathology; 2022 Feb; 80(3):485-500. PubMed ID: 34580909
[TBL] [Abstract][Full Text] [Related]
11. Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
Aherne S; Donnelly M; Ryan ÉJ; Davey MG; Creavin B; McGrath E; McCarthy A; Geraghty R; Gibbons D; Nagtegaal I; Lugli A; Kirsch R; Martin ST; Winter DC; Sheahan K;
Histopathology; 2024 Apr; ():. PubMed ID: 38629323
[TBL] [Abstract][Full Text] [Related]
12. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
[TBL] [Abstract][Full Text] [Related]
14. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
15. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
16. Predictive power of tumour budding for lymph node metastasis in colorectal carcinomas: A retrospective study.
Deb B; Jacob SE
Indian J Med Res; 2019 Dec; 150(6):635-639. PubMed ID: 32048628
[TBL] [Abstract][Full Text] [Related]
17. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
Zlobec I; Bihl MP; Foerster A; Rufle A; Lugli A
Histopathology; 2012 Nov; 61(5):777-87. PubMed ID: 22803799
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Horcic M; Koelzer VH; Karamitopoulou E; Terracciano L; Puppa G; Zlobec I; Lugli A
Hum Pathol; 2013 May; 44(5):697-705. PubMed ID: 23159156
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
[TBL] [Abstract][Full Text] [Related]
20. Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens.
Martinez-Ciarpaglini C; Fernandez-Sellers C; Tarazona N; Roselló S; Huerta M; Roda D; Mongort C; Ferrández A; Navarro S; Cervantes A
Histopathology; 2019 Oct; 75(4):517-525. PubMed ID: 31081121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
